Kano Therapeutics is a biotech company that focuses on targeted correction of gene-length stretches of DNA through a new class of biomaterial: circular single-stranded DNA. The company develops genetic payloads for genetic cures.

Kano Therapeutics

Kano Therapeutics is a founder-led biotech startup enabling safe, effective, and flexible correction of gene-length stretches of DNA through a new class of biomaterials. By building a “one stop shop” product development platform for single-stranded DNA templates that combines manufacturing, application, and computational tools we bridge the gap between editing genes and totally replacing them, empowering scientists, labs, and companies with the building blocks they need to cross the chasm to cures.

Explore our newest roles and join a team that's at the forefront of scientific innovation:
🌟 Senior Scientist, Downstream Process Development & Analytics
      🔗 Apply Now: https://lnkd.in/eBusJGPB
🌟 Sr. Research Associate/Scientist, Mammalian Cell Genome Editing
      🔗 Apply Now: https://lnkd.in/ecJrDsZE

Discover more about our career opportunities and how you can make an impact: 🔗 https://lnkd.in/e7fVWf2e

We're hiring! Kano is seeking a discovery research scientist to help bring our early pipeline programs closer to patients. 

If you're interested in joining our team apply here: https://lnkd.in/dSK-YXiQ

Kano seeks a hands-on discovery research leader to play a critical role in the development of our preclinical research function. 

You want to manage internal discovery and validation R&D projects and lead Kano’s internal and external program-specific research activities, including validating and de-risking lead candidates?

Apply here: https://lnkd.in/detAbT-x

We are thrilled to announce that we’ve been selected as a spoke of the Advanced Research Projects Agency for Health (ARPA-H) Investor Catalyst Hub network! We are excited to contribute to the community.

Bright Minds: Kano Therapeutics' CEO Floris Engelhardt discusses circular single-stranded DNA, and life as a startup.

She describes how her startup Kano is trying to use circular single-stranded DNA to correct gene length stretches of the genome.

Full video: https://lnkd.in/gguC8Her

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Aug 14, 2024 8:21 PM	845ce011
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	deecb674
crunchbase profile	general
li profile	general	Aug 14, 2024 8:21 PM	06e1c431
translate crunchbase fundingrounds	general
peers	general	Aug 14, 2024 8:21 PM	42765c30
news basic	general	Aug 14, 2024 8:21 PM	386c42e1
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:KANOTHERAPEUTICS

Kano Therapeutics